Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis

被引:4
|
作者
Ohashi, K. [1 ,2 ]
Sato, A. [14 ]
Takada, T. [2 ]
Arai, T. [3 ]
Kasahara, Y. [4 ]
Hojo, M. [5 ]
Nei, T. [1 ]
Nakayama, H. [2 ]
Motoi, N. [1 ]
Urano, S. [1 ]
Eda, R. [7 ,8 ]
Yokoba, M. [9 ]
Tsuchihashi, Y. [10 ]
Nasuhara, Y. [11 ]
Ishii, H. [6 ]
Ebina, M. [12 ]
Yamaguchi, E. [13 ]
Inoue, Y. [3 ]
Nakata, K. [1 ]
Tazawa, R. [1 ]
机构
[1] Niigata Univ, Med & Dent Hosp, Biosci Med Res Ctr, Niigata 9518520, Japan
[2] Niigata Univ, Grad Sch Med & Dent Sci, Div Resp Med, Niigata 9518520, Japan
[3] NHO, Kinki Chuo Chest Med Ctr, Osaka, Japan
[4] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Japan
[5] Natl Ctr Global Hlth & Med, Div Resp Med, Tokyo, Japan
[6] Kyorin Univ, Sch Med, Dept Resp Med, Tokyo, Japan
[7] NHO, Yamaguchi Ube Med Ctr, Ube, Yamaguchi, Japan
[8] Kurashiki Municipal Hosp, Kurashiki, Okayama, Japan
[9] Kitasato Univ, Sch Med, Dept Resp Med, Kanagawa, Japan
[10] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan
[11] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan
[12] Tohoku Univ, Sch Med, Dept Resp Med, Sendai, Miyagi 980, Japan
[13] Aichi Med Univ, Sch Med, Div Resp Med & Allergol, Dept Med, Aichi, Japan
[14] Cincinnati Childrens Hosp Med Ctr, Dept Pulm Biol, Cincinnati, OH USA
关键词
COLONY-STIMULATING FACTOR; THERAPY;
D O I
10.1183/09031936.00076711
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:777 / 780
页数:5
相关论文
共 50 条
  • [31] Relapsing Pulmonary Alveolar Proteinosis Treated with GM-CSF
    Alkhankan, E.
    Alkhankan, H.
    Bukamur, H. S.
    Amro, A.
    Megri, M. A.
    Alkhankan, F.
    Zeid, F. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [32] Generation of cDNA Library Encoding GM-CSF Autoantibody Sequences in Autoimmune Pulmonary Alveolar Proteinosis by Next Generation Sequencing
    Nakata, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [33] The Efficacy of GM-CSF Inhalation for Autoimmune Pulmonary Alveolar Proteinosis Is Influenced by Smoking Status
    Kitamura, N.
    Tazawa, R.
    Nakata, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [34] Characteristics Of Negative Gm-Csf Autoantibody Pulmonary Alveolar ProteINOSis (na-Pap) In Japan
    Ishii, H.
    Nakata, K.
    Tazawa, R.
    Inoue, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [35] The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review
    Ataya, Ali
    Knight, Vijaya
    Carey, Brenna C.
    Lee, Elinor
    Tarling, Elizabeth J.
    Wang, Tisha
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [36] CHARACTERISTICS OF NEGATIVE GM-CSF AUTOANTIBODY PULMONARY ALVEOLAR PROTEINOSIS (NA-PAP) IN JAPAN
    Ishii, H.
    Nakata, K.
    Tazawa, R.
    Inoue, Y.
    RESPIROLOGY, 2012, 17 : 76 - 76
  • [37] IgM-type GM-CSF autoantibody is etiologically a bystander but associated with IgG-type autoantibody production in autoimmune pulmonary alveolar proteinosis
    Nei, Takahito
    Urano, Shinya
    Motoi, Natsuki
    Takizawa, Jun
    Kaneko, Chinatsu
    Kanazawa, Hiroko
    Tazawa, Ryushi
    Nakagaki, Kazuhide
    Akagawa, Kiyoko S.
    Akasaka, Keiichi
    Ichiwata, Toshio
    Azuma, Arata
    Nakata, Koh
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2012, 302 (09) : L959 - L964
  • [38] AN ACUTE PRESENTATION OF AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS TREATED WITH WHOLE LUNG LAVAGE, RECOMBINANT GM-CSF AND RITUXIMAB
    Azzopardi, M.
    Masel, P.
    Laird, P.
    Duncan, A.
    RESPIROLOGY, 2014, 19 : 97 - 97
  • [39] LONG TERM FOLLOW-UP OF SERUM AUTOANTIBODY AGAINST GM-CSF LEVELS IN PATIENTS WITH AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS
    Matsumuro, A.
    Hirose, M.
    Arai, T.
    Sugimoto, C.
    Kitaichi, M.
    Akira, M.
    Inoue, Y.
    RESPIROLOGY, 2014, 19 : 28 - 28
  • [40] Plasmapheresis, GM-CSF, and alveolar proteinosis
    Kavuru, MS
    Bonfield, TL
    Thomassen, MJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (07) : 1036 - 1036